This Emetogenic Drugs market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain dynamics, and insights about new geographical markets. The market insights covered in Emetogenic Drugs report simplifies managing marketing of goods and services effectively.
Data Bridge Market Research analyses a growth rate in the emetogenic drugs market in the forecast period 2023-2030. The expected CAGR of emetogenic drugs market is tend to be around 14.2% in the mentioned forecast period. The market was valued at USD 1371.50 million in 2022, and it would grow upto USD 3967.57 million by 2030.
Access Full Report@
Market Overview
Emetogenic symptoms are associated with nausea and vomiting related to the cancer treatment such as chemotherapy, radiation therapy and drug therapy. Nausea and vomiting are the major side effects of cancer therapy. It is significant that nausea and vomiting must be controlled so the patient can continue the treatment and have a better quality of life. Majorly nausea and vomiting induced by patients on chemotherapy and radiation therapy of the brain, gastrointestinal tract, or liver also cause nausea and vomiting.
Global Emetogenic Drugs Market Scope and Market Size
The emetogenic drugs market is segmented on the basis of class, types of emesis, application, drug type, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
• Serotonin Receptor Antagonists (5-HT3 RAS)
• Neurokinin-1 Receptor Antagonist (NK1 RAS)
• 5HT3 RA/NK1 RA Combination
• Corticosteroids
• Olanzapine
• Others
Types of Emesis
• Acute
• Delayed
• Anticipatory
• Breakthrough
• Refractory
• Chronic
• Others
• Highly Emetogenic Chemotherapy
• Moderately Emetogenic Chemotherapy
• Low Emetogenic Chemotherapy
• Other
Drug Type
• Branded
• Generic
• Hospitals
• Specialty Clinics
• Others
Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Others
Key players operating in the emetogenic drugs market include:
• Heron Therapeutics, Inc.(U.S.)
• Sandoz International GmbH (Switzerland)
• Merck & Co., Inc. (U.S.)
• Eisai Co., Ltd (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Qilu Pharmaceutical Co.,Ltd (China)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• GSK plc (U.K.)
• Mundipharma International (U.K.)
• Baxter (U.S.)
• Bayer AG (Germany)
• Cipla Inc (U.S.)
• Sanofi. (France)
• Sun Pharmaceutical Industries Ltd. (India)
Browse Trending Reports:
Animal Antibiotics Antimicrobials Market – Industry Trends and Forecast to 2029
Myopia Treatment Market – Industry Trends and Forecast to 2030
Dementia Treatment Market – Industry Trends and Forecast to 2029
Sack Kraft Paper Market – Industry Trends and Forecast to 2028
Electric Impedance Tomography Market – Industry Trends and Forecast to 2029
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: –